Affiliation:
1. Affiliated Hospital of Inner Mongolia Medical University
2. People's Hospital of Inner Mongolia Autonomous Region
3. The 969th Hospital of the joint logistics support force of P.L.A
Abstract
Abstract
Background
RGCC (regulator of cell cycle) is a protein-coding gene, also known as RGC-32(response gene to complement 32 protein), which is an important regulatory gene of cell cycle progression. However, the relationship between RGCC and breast cancer prognosis and tumor immune cells remains unclear.
Methods and results
RGCC differential expression analysis was performed based on TCGA, GEO, UALCAN and HPA databases, respectively. Then, KM curve and ROC curve were constructed to evaluate the prognosis and diagnostic value of RGCC. In addition, Immune Infiltration Analysis was performed by ssGSEA. scTIME and cancerSEA databases were used to illustrate the relationship between RGCC and tumor immune cells at the single-cell level. Subsequently, the clinical relevance of RGCC was discussed and Nomogram and calibration curves were constructed. Finally, R package clusterProfiler was used for enrichment of the GO (Gene Oncology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways to explore the biological function of RGCC.
Results
Low expression of RGCC in breast cancer was associated with better overall survival (OS) and Disease Specific Survival (DSS), and ROC curve suggested that RGCC had a good diagnostic value. The expression of RGCC was positively correlated with the invasion levels of iDC, Macrophages, Neutrophils, CD8 T cells, and Th1 cells. RGCC was positively correlated with immunoinhibitors TGFB1 and immunostimulators C10orf54, CD40, CXCL12, CXCR4, IL6, NT5E, TNFRSF4, TNFRSF8 and TNFSF9 in BRCA. Single cell data showed that RGCC was highly expressed in Macrophages. RGCC mRNA expression was significantly correlated with Age, Histological type, T stage, HER2 status and PAM50. Mechanistically, we found that RGCC is closely related to cell adhesion and MHC Class II protein complexes. RGCC was associated with angiogenesis in two single-cell datasets.
Conclusions
RGCC may play an important role in cell proliferation and metastasis, and can be used as a prognostic biomarker to determine the prognosis of BRCA and immune invasion.
Publisher
Research Square Platform LLC
Reference47 articles.
1. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice;Hadadi E;Nature communications,2020
2. Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients;Li MJ;Onco Targets Ther,2016
3. Adrenomedullin inhibits tumor metastasis and is associated with good prognosis in triple-negative breast cancer patients;Liu LL;American journal of translational research,2020
4. Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer;Afghahi A;Clinical cancer research: an official journal of the American Association for Cancer Research,2018
5. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers;Caushi JX;Nature,2021